CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications.

Type
Public
HQ
Bedminster Township, US
Founded
2006
Size (employees)
14 (est)+56%
CorMedix was founded in 2006 and is headquartered in Bedminster Township, US
Report incorrect company information

CorMedix Office Locations

CorMedix has an office in Bedminster Township
Bedminster Township, US (HQ)
200 1430 US-206
Show all (1)
Report incorrect company information

CorMedix Financials and Metrics

CorMedix Revenue

Embed Graph
CorMedix's revenue was reported to be $329.33 k in FY, 2017
USD

Revenue (Q1, 2018)

23.2 k

Gross profit (Q1, 2018)

(5.4 k)

Gross profit margin (Q1, 2018), %

(23.1%)

Net income (Q1, 2018)

(10.2 m)

EBIT (Q1, 2018)

(10.2 m)

Market capitalization (18-Jul-2018)

21.1 m

Closing share price (18-Jul-2018)

0.3

Cash (31-Mar-2018)

8.2 m
CorMedix's current market capitalization is $21.1 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

2 k189.3 k210.1 k224.1 k329.3 k

Revenue growth, %

9359%11%7%

Cost of goods sold

201.6 k445.8 k318.7 k366.7 k115 k

Gross profit

(199.6 k)(256.5 k)(108.6 k)(142.6 k)214.4 k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

12.2 k39.7 k52.4 k31.3 k120 k35.9 k41.4 k16.5 k44.5 k39.6 k136.2 k23.2 k

Cost of goods sold

81 k54.5 k36.7 k17.3 k101.8 k35.4 k50.2 k187.2 k43.9 k93.6 k18.1 k28.6 k

Gross profit

(68.8 k)(14.8 k)15.8 k13.9 k18.2 k551 (8.8 k)(170.7 k)529 (54 k)118.1 k(5.4 k)

Gross profit Margin, %

(564%)(37%)30%45%15%2%(21%)(1034%)1%(137%)87%(23%)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

2.4 m4.3 m11.8 m8.1 m10.4 m

Accounts Receivable

Inventories

80 k166.7 k594.2 k

Current Assets

2.9 m5 m37.1 m21.8 m13.3 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

483.1 k9.2 m7.7 m5.9 m8.8 m24.1 m14.2 m13.2 m12 m9.8 m6.8 m7.9 m8.2 m

Inventories

270.5 k63.7 k278 k677.4 k461.4 k715 k699.1 k333.9 k157.5 k118.2 k94.9 k313.1 k578.9 k

Current Assets

1 m9.7 m8.2 m6.8 m9.7 m38.7 m39.3 m33.6 m31.2 m28.8 m14.9 m21.1 m9.4 m

PP&E

3 k33.6 k54.2 k46.9 k47 k44.7 k41.1 k34.8 k31.9 k75.8 k63.2 k57 k205.3 k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(9.1 m)(20.5 m)(18.2 m)(24.6 m)(33 m)

Depreciation and Amortization

36.9 k

Inventories

80 k(100.5 k)

Accounts Payable

939.8 k893.4 k1.7 m1.6 m157.5 k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(2.5 m)(16.7 m)3.5 m(5 m)(5.5 m)(4.1 m)(4.7 m)(4.2 m)(4.9 m)(9.1 m)(7.6 m)(10.2 m)

Depreciation and Amortization

19.4 k

Inventories

278 k677.4 k15.3 k

Accounts Payable

848.6 k740.3 k1.4 m1.1 m1.4 m1.6 m1.1 m1.8 m1.7 m1.8 m
USDY, 2018

Revenue/Employee

1.7 k

Financial Leverage

11.4 x
Show all financial metrics
Report incorrect company information

CorMedix Online and Social Media Presence

Embed Graph
Report incorrect company information

CorMedix News and Updates

Report incorrect company information

CorMedix Company Life and Culture

Report incorrect company information